Raymond James & Associates’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-26,297
| Closed | -$366K | – | 3830 |
|
|
2023
Q3 | $366K | Buy |
26,297
+1,888
| +8% | +$26.2K | ﹤0.01% | 3053 |
|
|
2023
Q2 | $561K | Buy |
24,409
+1,478
| +6% | +$34K | ﹤0.01% | 2844 |
|
|
2023
Q1 | $679K | Buy |
22,931
+6,150
| +37% | +$182K | ﹤0.01% | 2704 |
|
|
2022
Q4 | $419K | Buy |
16,781
+317
| +2% | +$7.91K | ﹤0.01% | 2995 |
|
|
2022
Q3 | $358K | Buy |
+16,464
| New | +$358K | ﹤0.01% | 3057 |
|